Beckman Coulter Diagnostics

22, Rue Juste-Olivier
1260 Nyon
Switzerland

Tel: +41 22 365 38 08
EUPublicRelations@beckman.com
www.beckmancoulter.com

News • Presented at ESCMID Global

Immunoassay analyzer extends menu with new hepatitis assays

Beckman Coulter Diagnostics announced ahead of the ESCMID Global congress (formerly ECCMID) that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.

Automation reimagines laboratory diagnostics service

San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman…

New sepsis marker speeds up detection and therapy

Sepsis is the cause of one in five deaths worldwide, killing nearly 11 million people each year, many of them children. It is also a major cause of disability, affecting millions more. To combat the…

Interview • Urinalysis for Covid-19 diagnostics

Automation to relieve pandemic pressure from laboratories

To provide a solution for the challenges of the coronavirus pandemic, Beckman Coulter recently launched the DxU Iris, a urinalysis solution which aims to improve lab workflows.

Minimising laboratory errors with automation

Staffing shortages, increased testing volumes and the need to improve turnaround times have led to labs seeking to streamline services. Automation is the key, thanks to the role it plays in…

Speeding up diagnostics to detect antibiotic resistance

Infectious disease diagnostics are notoriously slow. The gold standard for laboratory diagnosis of bacterial and fungal infection involves growing the pathogen from a clinical specimen – an…

News • Labs processing 2,000 to 5,000 tests a day

Workflow automation solutions for mid-volume laboratories

Clinical diagnostics company Beckman Coulter announced the European launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a…

News • Hematology

New tabletop analyzer to increase productivity and efficiency in the lab

Clinical diagnostics company Beckman Coulter announced the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories.…

News • Coronavirus infection response

SARS-CoV-2 IgG II antibody test launched in CE Mark countries

Clinical diagnostics company Beckman Coulter launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE Mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a…

Article • High-sensitivity troponin I assay

Speeding up diagnosis of myocardial infarction

The new generation troponin I assay unveiled by Beckman Coulter is helping improve heart attack diagnosis. Delivering high sensitivity, and rapid result turnaround times, every element of the Access…

News • In countries accepting CE Mark

Beckman Coulter launches SARS-CoV-2 IgM antibody test

Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test demonstrated 99.9% specificity with 1,400…

Article • Blood poisoning

Exploring the importance and challenges of early sepsis diagnosis

On the occasion of this year's World Sepsis Day, we spoke with Elena Sukhacheva, Ph.D., director of medical and scientific affairs at Beckman Coulter, about the status quo and outlook on sepsis…

News • COVID-19 diagnostics

SARS-CoV-2 IgG antibody test receives FDA Emergency Use Authorization

Beckman Coulter announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already shipped…

News • IgM/IgG identification

Coronavirus antibody test in development

In response to the global COVID-19 pandemic, Beckman Coulter announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed…

News • Backup from BARDA

Sepsis early detection algorithm receives development funding

Beckman Coulter, Inc. announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the…

News • Dry Unitized Reagent Assays

Beckman Coulter presents online cost benefit tool at AACC 2019

Beckman Coulter Life Sciences launched the online DURA Innovations calculator tool, a powerful cost benefit analysis resource to accompany its latest Cost Benefit Calculator Handbook. The free online…

Early sepsis indicator helps identifying patients at risk

The critical element of testing for sepsis lies not so much in the location but in the timing and rapidity of results, according to Professor Jeannine T. Holden from Beckman Coulter Early…

News • Flow cytometry lab

New ClearLLab IVD Reagents launched

Beckman Coulter is launching the ClearLLab 10C System for the clinical flow cytometry lab. The new system is the first 10-color IVD panel of immunophenotyping reagents cleared by the Food and Drug…

News • Total Laboratory Automation

TLA sets new standard for turnaround time

Beckman Coulter announced that the latest addition to its market-leading automation portfolio, the DxA 5000 total laboratory automation (TLA) solution has achieved European CE Mark and China Food and…

News • New hematologic biomarker

FDA clearance for early sepsis indicator

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug…

News • Symposium @ ECCMID 2019

How laboratories can help detect AMR and sepsis sooner

Beckman Coulter, a global leader in clinical diagnostics will be demonstrating its latest comprehensive solutions in microbiology, urinalysis and hematology at the 29th European Congress of Clinical…

Hematology: Advancements and future trends

While the role of the laboratory in disease diagnosis and management has expanded in recent years, causing an overwhelming rise in testing demands, the availability of skilled technologists and…

News • Diagnostic lab system

DxM MicroScan WalkAway System now available on the market

Beckman Coulter announced commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology…

News • Acute Coronary Syndrome

Access hsTnI assay rules out ACS in 2 hours

The clinical performance of Beckman Coulter's high-sensitivity troponin I (hsTnI) assay Access hsTnI has been validated in a study. Within 2 hours, the assay delivers an accurate assessment of…

News • New study

Prostate Health Index drastically cuts down biopsy rate

A study published in Prostate Cancer and Prostatic Diseases demonstrated that physicians elected to perform fewer biopsies when Prostate Health Index (phi) testing was included in their overall,…

News • Cloud computing

New tools to ease lab work

Beckman Coulter Diagnostics introduces a new integrated system of technologies and capabilities called DxONE, designed to ease data access and usability. DxONE was created in response to the…

News • FDA-cleared Procalcitonin (PCT)

Beckman Coulter Diagnostics expands chemistry menu

Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.

Article • Molecular diagnostics

A one-step system for faster turnaround of hospital samples

A new molecular diagnostics system is revolutionising analysis of hospital samples across an area of northern Italy. The Greater Romagna Area Hub Laboratory has recently installed the Beckman Coulter…

News • Unsung Heroes

CARES Award helps people living with HIV/AIDS

Beckman Coulter Life Sciences is launching an international HIV/AIDS award at the 2016 conference for the African Society for Laboratory Medicine (ASLM) being held in Cape Town, South Africa…

Article • Gold standard

Giant aims to inflate microbiology

At Europe’s largest meeting for clinical laboratories, Beckman Coulter stepped forward to welcome a new class of customers looking for familiar and reliable instruments.

Report: John…

A laboratory fit for a future decade

Fostering a collaborative way of working won the UK’s Dartford and Gravesham NHS Trust recognition as an elite public sector healthcare employer, recently judged one of the top 100 ‘Best Places…

Confidence in Hematology, Results with Beckman Coulter

Wallace Coulter, one of the founders of Beckman Coulter, was motivated by a belief that science should serve humanity. This was the inspiration behind the principle he invented that became the basis…

News • News

Beckman Coulter launches diagnostics system

Beckman Coulter Diagnostics will be showcasing its new DxN VERIS Molecular Diagnostics System at ECCMID 2015 in Copenhagen.

News •

Bio-Rad Laboratories and Beckman Coulter expands cooperation

Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company…

Article •

Long-term managed lab automation

The University Medical Center in Utrecht (UMCU), The Netherlands, is in the process of creating a multidisciplinary centre of excellence, able to manage resources efficiently while delivering the…

News •

Beckman Coulter to Acquire Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business…

News •

Beckman Coulter’s new assay for safer pregnancies

New Assay Is First to Standardize to World Health Organization’s 5th International Standard for Chorionic Gonadotropin

Article •

A new day for troponin in clinical practice

Beckman Coulter’s new Access AccuTnI+3 troponin I assay has received FDA clearance for its UniCel DxI series of immunoassay systems at the same time as having a new CE Mark approved on the UniCel…

Article •

New Benchtop Centrifuges from Beckman Coulter

The Allegra X-5 air-cooled benchtop centrifuge from Beckman Coulter Life Sciences is designed specifically for clinical sample preparation.

Article •

LEAN workflow analysis

This year’s EuroMedLab and IFCC-EFLM Congress came at a time when all hospitals face ever-increasing healthcare costs, aging populations and patients and GPs demanding more complex and novel…

Article •

Two new lab launches

Beckman Coulter, Inc. has released a new bench-top haematology analyser for mid- to high-volume laboratories, and upgraded software for HematoFlow.

Article •

Molecular diagnoses will become routine

Molecular diagnostics is one of the most important technological advances in clinical diagnostics, seeing the €3.6 billion market grow 10% in constant currency (CC) in 2010 and predicted continual…

Article •

Ultra-high throughput and advanced testing methods

During the IFCC and EuroMedLab congress in Berlin, Beckmann Coulter launched into Europe its AU 5800, which, the firm reports, improves processing time compared to current systems and therefore meets…

Article •

A novel prostate disease marker and index show increased clinical accuracy

The role of prostate-specific antigen (PSA) in prostate cancer detection continued to command attention at during the annual congress of the European Association of Urology (EAU) in March.

Article •

Partnership delivers improvements in pathology services

Southampton University Hospitals’ Department of Laboratory Medicine has recently transformed the way it delivers its pathology service, becoming one of the largest automation installations in the…

Article •

Beckman Coulter sold

USA - Over the past couple of decades, due to acquisitions California-based Beckman Coulter Inc has became one of the world’s largest manufacturers of in vitro diagnostics analysers and automation…

Article •

A journey towards full automation

St Jude Medical Center, in Fullerton, California, has always taken pride in its reputation as one of Southern California’s most respected and technologically advanced hospitals. With 384 licensed…

Article • Prostate cancer risk assessment

Novel p2PSA marker more accurate than PSA testing

The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality was given a boost in 2009 when the conclusive findings from the 10-year European Randomized Study…

Article •

Enhanced performance of Beckman Coulter's Analytical Ultracentrifuge

Newly designed centerpieces used in the Beckman Coulter XL-A and XL-I instruments - the only analytical ultracentrifuges on the market today - allow the systems to provide precise, repeatable…

Article •

Beckman Coulter Expands Drugs of Abuse Test

Beckman Coulter, Inc. has expanded its drugs of abuse test menu to include a DRI* Oxycodone Enzyme Immunoassay (OXYX). The assay is for the qualitative and semi-quantitative determination of…

Article •

A new instrument for mid-to-high volume labs

At Euromedlab (7-11 June, Austria), Beckman Coulter will demonstrate the new UniCel DxH 800 Coulter Cellular Analysis System.

Article •

A strategic acquisition of the Olympus Laboratory unit

Beckman Coulter Inc, manufacturer of medical test systems, has agreed to acquire the diagnostic systems portion of Olympus Corporation's life sciences business.

Article •

Ultra-clear resin pipette tips

The multichannel tips are also packaged in new cases that simplify handling and storage and facilitate recycling.

Article •

Beckman Coulter to aquire lab-based Diagnostics business from Olympus Corporation

Beckman Coulter, Inc., a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, and Olympus Corporation, a Tokyo-headquartered…

Article •

St Mary's Hospital Centre

The overall quality of laboratory operations has traditionally been evaluated using a combination of three variables: analytical quality, timeliness (turnaround time) and operational efficiency.

Article •

Update UniCel integrated systems

This summer, California-based Beckman Coulter Inc. began general distribution of its UniCel DxC 880i's integrated system in Europe.

Article •

Beckman Coulter Launches the UniCel® DxI 600 at EuroMedLab 2007

Beckman Coulter, Inc. has launched the next analyser in its series of in vitro diagnostic offerings, the UniCel® DxI 600 Access® Immunoassay System, an innovative immunochemistry instrument…

Article •

Beckman Coulter Launches the UniCel® DxI 600

Beckman Coulter has launched the next analyzer in its growing family of UniCel® systems, the UniCel DxI 600 Access® Immunoassay System. This instrument is designed for mid-volume laboratories, a…